As of close of business last night, Gritstone Bio Inc’s stock clocked out at $2.59, down -3.72% from its previous closing price of $2.69. In other words, the price has decreased by -$0.1000 from its previous closing price. On the day, 972729 shares were traded.
Ratios:
To gain a deeper understanding of GRTS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.20. In the meantime, Its Debt-to-Equity ratio is 2.02 whereas as Long-Term Debt/Eq ratio is at 1.89.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on February 28, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $4.
On March 28, 2023, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $8.B. Riley Securities initiated its Buy rating on March 28, 2023, with a $8 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 23 ’23 when Economides Vassiliki bought 12,000 shares for $1.90 per share. The transaction valued at 22,829 led to the insider holds 214,058 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GRTS now has a Market Capitalization of 253.99M and an Enterprise Value of 279.49M. For the stock, the TTM Price-to-Sale (P/S) ratio is 190.98 while its Price-to-Book (P/B) ratio in mrq is 4.87. Its current Enterprise Value per Revenue stands at 209.99 whereas that against EBITDA is -2.20.
Stock Price History:
The Beta on a monthly basis for GRTS is 0.40, which has changed by -2.63% over the last 52 weeks, in comparison to a change of 29.19% over the same period for the S&P500. Over the past 52 weeks, GRTS has reached a high of $3.33, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is 2.4618, while the 200-Day Moving Average is calculated to be 2.0203.
Shares Statistics:
It appears that GRTS traded 2.01M shares on average per day over the past three months and 1.24M shares per day over the past ten days. A total of 97.59M shares are outstanding, with a floating share count of 89.41M. Insiders hold about 8.82% of the company’s shares, while institutions hold 38.49% stake in the company. Shares short for GRTS as of Feb 29, 2024 were 8.22M with a Short Ratio of 4.09, compared to 8.99M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.43% and a Short% of Float of 9.51%.
Earnings Estimates
As of right now, 6 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.33 for the current quarter, with a high estimate of -$0.26 and a low estimate of -$0.39, while EPS last year was -$0.3. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.21 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$0.58 and -$1.47 for the fiscal current year, implying an average EPS of -$1.1. EPS for the following year is -$0.96, with 5 analysts recommending between -$0.6 and -$1.48.
